Read by QxMD icon Read

asistent heart

C Engin, F Ayik, E Oguz, B Eygi, T Yagdi, S Karakula, M Ozbaran
BACKGROUND: Because of the shortage of donor hearts, various ventricular asist devices (VAD) have been used in decompensated patients to prolong patient survival until a suitable heart becomes available. In this paper, we present our single-center report of adult patients in whom bridging was used with VAD. METHODS: We performed a retrospective review of 14 adult patients who underwent heart transplantation after insertion of a long-term VAD. The study spans from February 2006 until September 2010...
April 2011: Transplantation Proceedings
F DiƩvart, S Ragot, J Julien, D Herpin
Beta-blockers have been considered for decades as effective agents in preventing coronary events in hypertensive patients. Actually, the scrutiny of the available data arises some doubts over the real value of this pharmacological class. In primary prevention, the clinical benefits of beta-blockers are poorly documented: the studies conducted against placebo (MRC, IPPPSH...) did not show any significant differences regarding the rate of coronary events (except within non smokers); moreover, the beneficial effect of propranolol in preventing sudden deaths and silent myocardial infarctions has been reported byjust one retrospective analysis...
September 2005: Archives des Maladies du Coeur et des Vaisseaux
S Sack, E Mouton, P Defaye, N Dagres, U Wolfhard, H Wieneke, J Herrmann, O Oldenburg, A Golles, R Erbel et al.
PATIENTS AND METHODS: This prospective study analyzed the incidence of atrial arrhythmias in a population of 626 patients in 173 medical centers of eleven European countries and Japan with indication for a dual chamber pacemaker system. The accuracy of the new Automatic Interpretation for Diagnosis Assistance (AIDA) program which is included in Chorus pacemakers was evaluated and the AIDA analysis was compared to and proven with Holter monitoring. Data stored in the pacemakers' memories for the first 24 hours (D1) were compared with simultaneously recorded 24-hour surface electrocardiograms, and data stored over the following 28 days (D28) were examined against reported intercurrent symptoms...
February 2001: Herz
J Zhu, Z Xu, B Zhang
This paper reported four cases of acute coronary artery occlusion occurred during valve replacement procedure. Case 1 was of Marfan's syndrome who underwent Cabrol procedure. Case 2 was of congenital aortic bileaflet malformation with severe regurgitation and simple right coronary artery, who received the procedure of AVR. Both cases 3 and 4 suffered from rheumatic valve disease who were given DVR and tricuspid valve annuloplasty. All the cases had acute left coronary artery occlusion and did not revive after removal of aortic cross-clamp, which were immediately corrected by coronary bapass grafts from aortic to left descending branch with saphonous veins...
October 1995: Zhonghua Wai Ke za Zhi [Chinese Journal of Surgery]
P Hjemdahl, S V Eriksson, C Held, N Rehnqvist
Antianginal drug treatment reduces symptoms and ischemia but may also influence the prognosis of patients with stable angina pectoris. The Atenolol Silent Ischemia Study (ASIST) compared atenolol and placebo treatment (about 140 patient-years on each) in patients with mainly silent ischemia and found less aggravation of angina and a tendency toward fewer cardiac complications with atenolol treatment. The Total Ischaemic Burden European Trial (TIBET) compared slow release nifedipine, atenolol, or the combination (about 450 patient-years on each) and found no significant differences with regard to cardiac complications, a nonsignificant trend toward better prognosis on combined treatment, and more side effects on nifedipine alone compared with the other treatments...
June 20, 1996: American Journal of Cardiology
T Takahama, F Kanai, K Onishi, Z Yamazaki, A Furuse, T Yoshitake
To establish ideal anticoagulation therapy for use with a left ventricular assist device, a study was done administering various anticoagulants: heparin, argatroban, a prostacyclin analogue combined with a protease inhibitor, or a protease inhibitor alone. Cardiac asisting by LVAD without any anticoagulants results in marked activation of blood coagulation or fibrinolysis. Administration of argatroban, as well as heparin, produces a bleeding tendency. Administration of a protease inhibitor (nafamostat mesilate, FUT-175) as a sole anticoagulant induces activation of the blood coagulation system to some extent, but it is within acceptable limits...
July 1995: ASAIO Journal: a Peer-reviewed Journal of the American Society for Artificial Internal Organs
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"